Introduction
============

Endogenous retroviruses (ERVs) are viral elements that are present in the genomes of virtually all species including human beings ([@B37]). At least 8% of the human genome is composed of endogenous retroviral sequences ([@B49]). These sequences were integrated into the human genome in the course of the evolution ([@B26]). The great majority of ERVs are stabilized in the genome, but there is still ongoing or potential ERV genotype modification from parents to offspring through generations. Like other genes, ERVs are susceptible to mutations and proviral DNAs are predisposed to accumulate mutations as these sequences are usually not vital for the host survival and thus not under strong selective pressure. The majority of ERVs integrated in our genome is not competent to replicate and most ERV sequences are presumably silent ([@B42]). Nevertheless, about one third of all ERV sequences in the genome were found to be transcriptionally active ([@B67]). Some of these sequences still have open reading frames (ORFs) and, therefore, have the potential to code for a protein or peptide ([@B25]; [@B92]). ERVs can be reactivated by some herpes viruses such as Epstein--Barr virus ([@B59]). Another possibility is the reactivation of ERV expression by hypoxia ([@B45]; [@B48]). ERV-encoded superantigens might lead to hyper-stimulation of the immune system and tissue damage. In addition, fusogenic activity of ERV envelope proteins might have direct cytopathic effects which might be involved in MS pathogenesis independent on autoimmune mechanisms. Indeed, cell fusion has been detected in MS brain lesions as well as in animal models of MS ([@B44]; [@B75]). A working model for ERV reactivation and consequences is presented in **Figure [1](#F1){ref-type="fig"}**.

![A working model for ERV reactivation. ERVs constitute an integral part of our genome. Under normal conditions, expression of ERVs is switched off epigenetically. Triggered by diverse factors like hypoxia, reactivation of ERV expression can be induced. ERV-encoded proteins can act as immunostimulatory superantigens or induce cytopathic effects, e.g., cell fusion.](fmicb-09-00287-g001){#F1}

Endogenous retroviruses have contributed to certain physiological genes (i.e., syncytins) through modifications ([@B12]; [@B63]; [@B81]) and can sometimes probably protect the host against exogenous retrovirus infections ([@B58]). On the other hand, ERVs have also been found to be associated with different diseases ([@B24]; [@B7]), e.g., schizophrenia and bipolar disorder ([@B68]), type 1 diabetes mellitus ([@B61]), or cancer ([@B35]) as well as multiple sclerosis (MS) ([@B69]; [@B21]). Several ERVs are considered to be associated with MS ([@B19]). For example, human ERV-W envelope mRNA expression was found to be selectively up-regulated in brain tissue from individuals with MS as compared with controls ([@B3]). In addition, HERV-H Env and HERV-W Env are increased on the surface of B cells and monocytes of MS patients ([@B16]).

Multiple sclerosis is a chronic immune-mediated inflammatory disease of the central nervous system with characteristic patchy demyelination. It is the most common chronic disabling CNS disease in young adults and affects about 2.3 million people around the world ([@B15]). The etiology of MS has not been completely decoded so far; the causes of MS are hypothesized to be multifactorial including environmental influences ([@B41]) as well as epigenetic and genetic factors ([@B47]; [@B13]). Commonly an autoimmune attack against myelin autoantigens is considered as the main occurrence in the pathogenesis of MS ([@B39]; [@B66]). Additionally, ERVs are discussed to contribute to MS ([@B86]; [@B27]). Besides, MS has been linked to hypoxia for decades (e.g., [@B29]; [@B5]; [@B84]). Hypoxic damage is hypothesized to be a factor in MS pathogenesis, because some patterns of demyelination are similar to white matter ischemia ([@B50]).

In the present study, we analyzed the effect of hypoxia-mimetic cobalt chloride (CoCl~2~) on human neuronal-like SH-SY5Y neuroblastoma cells for changes in gene expression profiles in contrast to un-stimulated cells. Genes up-regulated in this model are considered to indicate transcriptionally active chromatin regions which are susceptible also for ERV reactivation. Therefore, the vicinity of up-regulated genes was scanned for endogenous retrovirus sequences in order to identify possible ERV that might be involved in the link between hypoxia and MS. In addition, we analyzed the possible immune modulatory activity of the identified syncytin 2 in the A673 cell line system. We used this system because the immunostimulatory activity of A673 cells is well-characterized ([@B82]; [@B62]; [@B72]) and they display similar gene expression and splicing features as neuronal cells ([@B14]). The immunostimulatory activity of this model cell line has been shown to be susceptible to transgenic expression of varying molecules like interleukin 2 ([@B82]), CD137 ligand ([@B62]), or OX40 ligand ([@B72]).

Materials and Methods {#s1}
=====================

Cell Lines and Cell Culture
---------------------------

Human SH-SY5Y neuroblastoma cells ([@B10]) were obtained from the Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ, Braunschweig, Germany). A673 Ewing sarcoma cells ([@B34]) were obtained from the American Type Culture Collection (Manassas, VA, United States) All cells were cultured in Dulbecco's Modified Eagle Medium (DMEM, PAA, Pasching, Germany), supplemented with 10% fetal calf serum, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37°C in a humidified atmosphere with 5% CO~2~. For simulation of hypoxia, a fresh stock solution (10 mM) of CoCl~2~ was prepared in water and added to the medium to obtain desired final concentrations. SH-SY5Y cells were treated for 24 h at a cell density of 1 × 10^6^ cells/mL with either 0 μM CoCl~2~, 100 μM CoCl~2~, or 200 μM CoCl~2~. The experiment was repeated twice for the gene expression analysis with microarrays and three times for the gene expression analysis with polymerase chain reaction (PCR).

Gene Expression Analysis
------------------------

RNA was isolated using GeneMatrix Universal RNA Kit (roboklon, Berlin, Germany). RNA extracted from the cells was treated with DNase (roboklon, Berlin, Germany) to remove genomic DNA. Occasionally absence of DNA contamination was proved by using isolated RNA without reverse transcription as template for PCR. Global gene expression in SH-SY5Y cells was analyzed using Affymetrix Human Exon 1.0ST arrays (Affymetrix, Santa Clara, CA, United States). Affymetrix cel files were processed with Expression Console 1.1 (Affymetrix) at gene level (core; library version: huex-1_0-st-v2.na36.1.hg19). Calculations were performed with the MAfilter software ([@B94]). Values of cobalt (II) chloride treated samples had to be three times higher than controls and signal intensities (RMA normalized, linear values) had to be above 100 to be considered as differentially expressed. Analysis was performed separately for cells treated with 100 μM CoCl~2~, or 200 μM CoCl~2~. For further analysis we included all threefold up-regulated genes that were found in both replications. Microarray cell files have been submitted to the Gene Expression Omnibus (GEO) data base (GSE107333).

Identification of Endogenous Retrovirus Sequences
-------------------------------------------------

The chromosomal locations of the up-regulated genes were analyzed for the presence of putative ERV sequences essentially as described ([@B17]). For this end, we analyzed the 2 Mbp surrounding each individual gene for the presence of ORFs with a minimal length of 1 kb by using Mobyle 1.5 ([@B73]). Identified ORFs were analyzed using BLASTP ([@B2]) against the NCBI database of retro-transcribing viruses (taxid 35268) with the reference genome GRCh38 (primary assembly).

Polymerase Chain Reaction
-------------------------

One microgram of the isolated RNA was transcribed into cDNA and used as a template for PCR. Real-time quantitative reverse transcription-PCR (qRT-PCR) was performed using Go Taq pPCR master mix (Promega, Mannheim, Germany) using 10 μL Go Taq pPCR master mix, 7 μL water, 1 μL forward primer, 1 μL reverse primer (25 μM) and 1 μL cDNA. PCR conditions were: 94°C, 30 s; 60°C, 30 s; 72°C, 45 s (40 cycles). Gene expression was calculated with the 2^-ΔΔCt^ method ([@B55]). Conventional PCR was performed using 2 μl of the cDNA, 5 μl Green GoTaq Buffer (Promega, Mannheim, Germany), 0.5 μl of 10 mM dNTPs (Fermentas, Sankt Leon-Rot, Germany), 0.25 μl of each of the two primers (25 μM), 0.2 μl GoTaq polymerase (5 U/μl; Promega) and 16.8 μl water. All used primer sequences are listed in **Table [1](#T1){ref-type="table"}**. The amplification protocol included an initial denaturation step at 95°C for 5 min, followed by 40 cycles with denaturation at 95°C for 60 s; primer annealing at 60°C for 60 s; amplification at 72°C for 90 s; and a final extension step at 72°C for 5 min. PCR products were subjected to agarose gel (1.5%) electrophoresis in the presence of ethidium bromide.

###### 

Primer combinations used in this study.

  Target^a^     Primer sequences (5′--3′)
  ------------- -------------------------------
  ACTB          TAC AAT GAG CTG CGT GTG GC
                CGG ACT CGT CAT ACT CCT GC
  HERV-FRD      CCC TCA CCC CCT TAT TTC AT
                TTT GAA GGA CTA CGG CTG CT
  HERV-FRD^b^   ACC ATG GGC CTG CTC CT
                TCC TCC TTA GAA GGG TGA CTC
  EWSR1-FLI1    GGC CAA GAT CAA TCC TCC AT
                ATG GAG GAT TGA TCT TGG CC
  LIPI          AAC CAG CCC AAT CAG ACA AC
                AAT CAC TGG CCA GGA CAT TC
  NEDD9         CAC CGC AGT GCT TAA TGC TG
                TCA CGG GGG TTA TCA CCT TTT T

If not otherwise stated, primer combinations were used for qRT-PCR.

a

ACTB, actin beta; HERV-FRD, syncytin 1; EWSR1-FLI1, Ewing sarcoma breakpoint region 1-Friend leukemia virus integration site 1; tumor specific gene fusion; LIPI, lipase member I (cancer-testis antigen 17); NEDD9, neural precursor cell expressed developmentally down-regulated protein 9.

b

Used for conventional PCR only.

Cloning of *HERV-FRD* in pIRES2-AcGFP1 Vector
---------------------------------------------

DNA (PCR product from SH-SY5Y cells) from the agarose gel was extracted with GeneJet Gel Extraction Kit (Thermo Fisher, Waltham, MA, United States), ligated in vector pGEM-T Easy (Promega) and transformed in *Escherichia coli* XL1-Blue. The DNA of one overnight colony was isolated with GeneJET Plasmid Miniprep Kit (Thermo Fisher, Waltham, MA, United States). DNA and vector pIRES2-AcGFP1 (Clontech, Mountain View, CA, United States) were digested with *Sac*I and *Sac*II. After agarose gel purification, ligation, and transformation into *Escherichia coli* XL1-Blue, individual clones were sequenced by using HERV-FRD specific primers. For sequencing, a 10 μL sequencing mix was used that contained 6.8 μL HPLC water, 0.2 μL sequence-specific sequencing primers (10 μM), 2.0 μL BigDyeTerminator v1.1 Cycle Sequencing buffer (Applied Biosystems, Foster City, CA, United States), 2.0 μL BigDyeTerminator v1.1 Cycle Sequencing Mix and 10 ng DNA. Sequence analysis was performed using ABI Prism^TM^ 310 Genetic Analyzer (Applied Biosystems). A clone with complete HERV-FRD ORF was used for further analysis. This clone differs from the reference sequence by a silent C to T transition (corresponding to base 1,384 in reference sequence NM207582).

Transfection
------------

For transient expression, SH-SY5Y cells and A673 cells were cultured for 24 h and then transfected with the appropriate vectors using PromoFectin (PromoKine, Heidelberg, Germany) according to the manufacturer's protocol. For stable expression, cells were treated in the same way. After 24 h they were put under selection with the antibiotic G418.

Mixed Lymphocyte Tumor Cell Culture (MLTC) and Flow Cytometry
-------------------------------------------------------------

Peripheral blood mononuclear cells (PBMC) were prepared and mixed lymphocyte tumor cell culture (MLTC) was performed as described elsewhere ([@B82]; [@B31]). Detection of surface antigens on PBMC by flow cytometry was performed as described elsewhere ([@B40]). The following phycoerythrin labeled antibodies have been used: anti-CD3 clone SK7, anti-CD8 clone RPA-T8, and anti-CD25 clone 2A3. All antibodies were purchased from Becton Dickinson (Heidelberg, Germany) and all samples were analyzed on a FACScan instrument (Becton Dickinson) using CellQuestPro software (Becton Dickinson).

Results and Discussion
======================

According to our stringent filter criteria (see section "Materials and Methods"), only five genes were found to be strongly up-regulated in SH-SY5Y cells after treatment with cobalt chloride. These genes include (in alphabetical order) *CLU* (clusterin), *GPX3* (glutathione peroxidase 3), *IGF2* (insulin-like growth factor 2), *NEDD9* (neural precursor cell expressed, developmentally down-regulated 9), and *SLC7A11* \[solute carrier family 7 (anionic amino acid transporter light chain, Xc-system), Member 11\]. The up-regulated genes indicate transcriptionally active chromatin regions which might be susceptible for reactivation of other genetic elements like ERVs.

*CLU* (also known as apolipoprotein J, testosterone-repressed prostate message-2, or sulfated glycoprotein-2) encodes a glycoprotein which is nearly ubiquitously distributed in human tissues ([@B43]). It is a 75--80 kDa heterodimer and a molecular chaperone which is normally secreted but in conditions of cellular stress, it can be transported to the cytoplasm where it can bind to BAX and inhibit neuronal apoptosis ([@B64]). *CLU* expression has been associated with tumorigenesis of various malignancies, including tumors of the prostate, colon, and breast ([@B79]). Variants in the clusterin gene are also associated with the risk of Alzheimer's disease ([@B77]), dementia ([@B91]), and stroke ([@B36]). In astrocytes of MS white matter lesions an elevated expression of clusterin was detected ([@B87]). All of these diseases represent states of increased oxidative stress, which in turn, promotes amorphous aggregation of target proteins, increased genomic instability and high rates of cellular death ([@B85]).

*GPX3* (also known as plasma or extracellular glutathione peroxidase) encodes a protein which functions in the detoxification of hydrogen peroxide. Most of the *GPX3* mRNA is kidney-derived ([@B6]), but it is also expressed by heart, lung, liver, brain, breast, and gastrointestinal tract ([@B20]; [@B83]). In human cancer *GPX3* promotor down-regulation and hyper-methylation is rather common ([@B96]; [@B18]). *GPX3* expression and *GPX3* hyper-methylation can thus be used as biomarkers for different kind of cancer ([@B95]; [@B97]). *GPX3* works as a tumor suppressor for example in colitis-associated carcinoma ([@B8]) and in hepatocellular carcinoma ([@B70]). In initial MS lesions *GPX3* was found to be downregulated (\>2 log~2~-fold) compared to control ([@B30]).

*IGF2* encodes a protein with high homology to pro-insulin ([@B56]). IGF2 contains 10 exons and 4 promoters so that several alternatively spliced transcripts are possible ([@B28]). The *IGF2* gene is imprinted: the paternal *IGF2* allele is transcribed whereas the maternal allele is silent ([@B33]). As a growth factor it is especially expressed in many tissues in early stages of embryonic and fetal development ([@B38]). In adults, *IGF2* is preferentially expressed in liver and brain ([@B28]). IGF2 regulates normal cell growth and proliferation. Moreover, it plays a role in the growth and development of tumors: epigenetic changes at this locus are for example associated with Wilms tumor, Beckwith--Wiedemann syndrome, or rhabdomyosarcoma ([@B9]).

*SLC7A11* (also known as xCT) encodes a protein that is member (together with *SLC3A2*) of a heterodimeric, sodium-independent, anionic amino acid transport system that is highly specific for cysteine and glutamate ([@B76]). While SLC7A11 seems to induce the transport activity, SLC3A2 leads to the surface expression of the system ([@B89]). SLC7A11 seems to contribute to different kinds of cancer, including, e.g., malignant glioma ([@B74]) or breast cancer ([@B54]). In tumor cells, the amino acid transport system plays a critical role in regulating intracellular glutathione levels ([@B65]) and glutathione has been broadly implicated in chemotherapy resistance ([@B32]). Besides, *SLC7A11* is significantly up-regulated in post-mortem spinal cord samples from MS patients ([@B53]). SLC1A11 is a member of the solute carrier family, a large gene family that contains several receptors for retroviruses. Interestingly, two members of this family (SLC1A4, SLC1A5) have also been suggested as receptors for ERV ([@B51]). A function as receptor for viruses has not been described for SLC1A11.

*NEDD9* (also known as *CasL* and *HEF1*) encodes a protein which regulates diverse cellular processes that are relevant to cancer, like cell attachment, migration, invasion, apoptosis, or cell cycle regulation ([@B80]; [@B78]). Furthermore, *NEDD9* seems to play a role in the nervous system as there is some association between one *NEDD9* variation and the susceptibility of late-onset Alzheimer's disease and Parkinson's disease ([@B52]). As it is involved in TGFβ-mediated differentiation into the neuronal lineage and *NEDD9* possibly promotes a progenitor status that renders the cells competent to differentiation into neurons ([@B90]). It is enriched in neural progenitor cells ([@B1]) and its down-regulation is linked to neuronal lineage commitment ([@B4]).

Based on our search strategy (see section "Materials and Methods"), we found in the vicinity of the up-regulated genes large (\>1,000 bp) ORFs (from 11 in the vicinity of *NEDD9* to 169 in the vicinity of *IGF2*). For all genes, these ORFs included candidates that passed the default threshold of the NCBI BLASTP implementation \[expect (E) value \< 10\] against the database of retro-transcribing viruses. For four of the genes (all with the exception of SLC7A11) these BLASTP hits include envelope sequences from retro-transcribing viruses. The E-values for nearly all of these hits were higher than 0.01 and, therefore, are not convincing retroviral (ERV) sequences. However, we found one hit with very high similarity to retroviral envelope proteins in the vicinity of NEDD9 (see Supplementary Figure [1](#SM1){ref-type="supplementary-material"}).

We validated up-regulation of *NEDD9* in CoCl~2~ treated SH-SY5Y cells by qRT-PCR (**Figure [2](#F2){ref-type="fig"}**). Our results are in agreement with observations from other groups also demonstrating that *NEDD9* is induced by hypoxia ([@B60]; [@B46]).

![Expression of *NEDD9* in SH-SY5Y cells. Expression of *NEDD9* was analyzed in SH-SY5Y cells under different culture conditions by qRT-PCR. Cells were cultured in absence of CoCl~2~ (water control), with 100 μM of CoCl~2~ or with 200 μM of CoCl~2~. Presented are means and standard deviations from three independent experiments. For comparative analysis, beta actin was used as housekeeping control and the median expression of all samples was set as one.](fmicb-09-00287-g002){#F2}

The BLASTP hit in the vicinity of *NEDD9* (accession number [CAB94192.1](CAB94192.1); see Supplementary Figure [1](#SM1){ref-type="supplementary-material"}) represents a sequence ("HERV-H/env62") of the human HERV-H family. With about 1,000 elements the HERV-H family is one of the largest HERV families in the human genome ([@B93]). Analyzes showed that there are three envelopes with large ORFs corresponding to potential 59-, 60-, and 62-kDa translational products ([@B22]). Moreover, the higher HERV seroreactivity in patients with active MS correlates with the higher levels of HERV-H Env expression on B cells and monocytes ([@B16]).

The sequence in the vicinity of *NEDD9* is identical to the human endogenous retrovirus group FRD, member 1 (*HERV-FRD*). *HERV-FRD* is located in an intron of the small integral membrane protein 13 (*SMIM13*). The close association between NEDD9 and SMIM13 is highly conserved in vertebrates. However, in non-primate vertebrates, *HERV-FRD* is absent (**Figure [3](#F3){ref-type="fig"}**). *HERV-FRD* entered the primate genomes more than 40 million years ago ([@B23]). It has inactivating mutations in the *gag* and *pol* genes whereas the envelope glycoprotein gene is preserved ([@B71]). The encoded protein product is called syncytin 2 ([@B11]) which plays a major role in placental development and trophoblast fusion ([@B57]; [@B88]). The protein has the characteristics of a typical retroviral envelope protein, including a cleavage site that separates the surface and transmembrane units which together form a heterodimer of the mature syncytin 2 ([@B71]). Syncytin 2 can induce cell-cell fusion ([@B11]).

![Organization of the *NEDD9/SMIM13/HERV-FRD* region in humans and other species. **(A)** *HERV-FRD* is located in the intron of *SMIM13*. SMIM13 and NEDD9 are located tail-to-tail orientated on human chromosome 6. **(B)** Comparison of the *SMIM13/HERV-FRD* region in different vertebrate species. Red: exons of *SMIM13;* green: *SMIM13* intron; yellow: *HERV-FRD.*](fmicb-09-00287-g003){#F3}

In our model we found up-regulation only for the mentioned five genes and not for the associated ERVs and we have no evidence that ERVs are functionally involved in up-regulation of the genes or *vice versa*. From our data we only found HERV-FRD to be a candidate for a possible association between hypoxia and ERVs in MS. Other factors (e.g., patient specific polymorphisms) might be necessary to induce expression of the ERVs and subsequent effects. Under such conditions, it seems possible that over-expression of syncytin 2 in the brain, e.g., as a consequence of local hypoxia, elicits an immunomodulating activity. Therefore, we tested whether syncytin 2 overexpression lead to altered immunostimulatory activity in the well-characterized A673 model system ([@B82]; [@B72]). HERV-FRD transfected A673 cells retained the expression of tumor associated antigens (**Figure [4A](#F4){ref-type="fig"}**). However, we were not able to find altered immunostimulatory activity of transfected cells (**Figure [4B](#F4){ref-type="fig"}**) in this system. Further investigations are needed to analyze possible immunomodulatory properties.

![Absence of immunomodulatory effects of *HERV-FRD* transfected A673 cells. A673 cells were transfected with *HERV-FRD* or with empty vector (mock). **(A)** RNA from transfected cells were analyzed for presence of *HERV-FRD* and the Ewing sarcoma specific transcripts *EWSR1-FLI1* and *LIPI*. **(B)** Transfected cells were used as stimulatory cells in mixed lymphocyte/tumor cell cultures. Stimulated cells were analyzed for presence of T cells (CD3), cytotoxic T cells (CD8), and activated lymphocytes (CD25). Presented are means and standard deviations from three independent experiments.](fmicb-09-00287-g004){#F4}

Taking together, our study shows changes in gene expression profiles of hypoxia-mimetic CoCl~2~ treated human neuronal-like SH-SY5Y cells in contrast to untreated cells. Five genes were found to be strongly up-regulated: CLU, GPX3, IGF2, NEDD9, and SLC7A11. Three of them (CLU, GPX3, and SLC7A11) showed in the past some associations to MS. The identified ERV in the vicinity of NEDD9 might thus be involved in the association between hypoxia and MS.
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